Navigation Links
GenomeQuest, Inc. Announces Digital Gene Expression Solution Within Its Sequence Data Management Platform
Date:5/5/2009

DigEx Solution offers completely interactive gene-level database to explore, understand, manage, and share next-generation sequencing DigEx runs.

WESTBOROUGH, Mass., May 5 /PRNewswire/ -- GenomeQuest, Inc., the leader in sequence data management, today announced that it has released a Digital Gene Expression Workflow designed to enable researchers working with next-generation sequencing data. The Digital Gene Expression Workflow is the second such workflow to be delivered by GenomeQuest (March 2, 2009 - GenomeQuest Launches Rapid Annotation Pipeline) that allows researchers to analyze hundreds of millions of raw reads and explore the results in their web browser within the GenomeQuest web-application.

"Our customers are excited by the exploratory nature of our Digital Gene Expression workflow, which enables them to interact directly with their data," said Richard Resnick, VP of Software and Services. "Of course they get intuitive gene expression reports, an integrated gene viewer, drill downs on individual alignments, and clickable, queryable gene and annotation databases. But they also get the innate ability to use and share previous experiments as the annotation for future experiments."

The Digital Gene Expression Workflow is fully cross-platform, working with Illumina, SOLiD, Helicos and 454 reads. The workflow is enabled by GenomeQuest's high-speed commercial-grade algorithms, data management structure, and powerful compute cluster to deliver results within hours.

Visit the GenomeQuest website for a recorded demonstration and the Application Note - http://www.genomequest.com/solutions/Digital_Gene_Expression.html

About GenomeQuest, Inc.

GenomeQuest, Inc. is the leading sequence data management company providing applications and services to search, manage, analyze and mine the world's sequence data. The company's flagship product, GenomeQuest(TM), is a web-based sequence data management and analysis platform that enables users to exploit genomic information resources including next-generation sequencing tools and worldwide biological sequence reference databases. GenomeQuest's customers leverage high-speed algorithms and sophisticated analysis and reporting to transform sequence data into functional knowledge, on-demand. GenomeQuest delivers genomic data access, management, and utility to over 160 leading life science companies worldwide.

GenomeQuest, Inc., is headquartered in Westborough, Massachusetts. For more information, call (508) 616-0100, or visit www.genomequest.com.


'/>"/>
SOURCE GenomeQuest, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine
2. NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents
3. Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
4. SENOMYX ANNOUNCES NESTLES SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
5. American Oriental Bioengineering Announces May 2009 Conference Participation
6. Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
7. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
8. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
9. Rigel Announces First Quarter 2009 Financial Results
10. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
11. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/4/2016)... ... 04, 2016 , ... Morf Media Inc ., shaping ... FDA compliance training course, Writing Effective SOPs (Standard Operating ... course on Morf Playbook—now conveniently available on smartphones and PCs--provides step by step ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Sangamo BioSciences, ... genome editing, announced today that Edward Lanphier , ... update on the progress of Sangamo,s ZFP Therapeutic ® ... business strategy at 2:40 pm ET on Thursday, February ... Annual Global Healthcare Conference. The conference is being held ...
Breaking Biology Technology:
(Date:2/1/2016)... smart wallet ( www.wocketwallet.com ) announces the launch of a new video ... Las Vegas , where Joey appeared at the Wocket ... Vegas , where Joey appeared at the Wocket booth to meet ... filmed at the Consumer Electronics Show (CES2016) in Las Vegas ... greet fans. --> --> The ...
(Date:1/25/2016)... 2016  Glencoe Software, the world-leading supplier of image ... will provide the data management solution OMERO Plus for ... Photo - ... Phenotypic analysis measures the characteristics and behavior ... between states such as health and disease, the presence ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
Breaking Biology News(10 mins):